Potential effectiveness of Vitrakvi (Larotrectinib) for treating types of solid tumors carrying NTRK genes and the impact of TRKC mutations

Vitrakvi is a cancer treatment that targets solid tumors with NTRK gene fusion. NTRKs are rare genetic effects that can arise in tumors from several organs, including the lungs, thyroid glands, and intestines. This study sought to identify the position at which Vitrakvi binds to tropomyosin recepto...

Full description

Saved in:
Bibliographic Details
Main Author: Ali Adel Dawood
Format: Article
Language:English
Published: Universidad Politécnica Salesiana 2025-04-01
Series:La Granja: Revista de Ciencias de la Vida
Subjects:
Online Access:https://lagranja.ups.edu.ec/index.php/granja/article/view/9706
Tags: Add Tag
No Tags, Be the first to tag this record!